Search

Your search keyword '"Supino, Phyllis"' showing total 205 results
Start Over Author "Supino, Phyllis"
205 results on '"Supino, Phyllis"'

23. Participant evaluation and cost of a community-based health promotion program for elders

Author

Rogers, John, Grower, Ronnie, and Supino, Phyllis

Subjects
Health education -- Evaluation, Medical case management -- Evaluation, Community health services for the aged -- Evaluation
Abstract

JOHN ROGERS, MD, MPH RONNIE GROWER, MA PHYLLIS SUPINO, EdD This work was done when the authors were with the Department of Family Medicine, Robert Wood Johnson Medical School, University […]

Published
1992

26. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance

Author

Rosen, Stacey E., Borer, Jeffrey S., Hochreiter, Clare, Supino, Phyllis, Roman, Mary J., Devereux, Richard B., Kligfield, Paul, Bucek, John, Fishman, Dawn, and Chlouverakis, Gregory

Subjects
Mitral valve insufficiency -- Physiological aspects, Mitral valve prolapse -- Complications, Health
Abstract

The natural history of patients with severe nonischemic mitral regulation (MR) from mitral valve prolapse, who are asymptometic or minimally symptomatic and have normal right ventricular (RV) and left vertricular (LV) performance, has not been evaluated previously. To define natural history in this population and to determine if any objective variables could predict disease progression, 31 patients were followed annually with severe MR due to prolapse, who at entry were asymptomatic or minimally symptomatic and had normal RV and LV performance at rest by radionuclide cineangiography. Average follow-up in patients not reaching surgical and point was 4.7 years. The Kaplan-Meier product limit estimates were used to determine the rate of progression to either 'operable' symptoms or to previously defined 'high risk' ventricular performance descriptors, if the after occurred first. Univariate comparisons of Kaplan-Meier curves and multivariate Cox proportional hazards analyses were used to define prognostically important variables measured at entry. Fourteen patients developed symptoms warranting referral for operation; none developed high-risk ventricular performance descriptors. The annual end point risk was 10.3%. Of all covariates, only change in RV ejection fraction from rest to exercise was significantly associated with disease progression. Annual risk of progression to surgical end point was 4.9% in the subgroup in which this parameter increased with exercise and 14.7% in the subgroup without an increase (p = 0.04). Patients with severe MR due to mitral valve prolapse, who are asymptomatic or minimally symptomatic with normal ventricular performance, can be expected to progress to surgical indications at an annual rate of 10.3%. The change in RV ejection fraction during exercise is useful in predicting the likelihood of such progression. (Am J Cardiol 1994;74:37

Published
1994

27. Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events

Author

Barbut, Denise, Borer, Jeffrey S., Gharavi, Azuddin, Wallerson, Donald, Devereux, Richard B., Supino, Phyllis, and Suite, Nicholas D.A.

Subjects
Anticardiolipin antibodies -- Physiological aspects, Mitral valve insufficiency -- Physiological aspects, Aortic valve insufficiency -- Physiological aspects, Cerebral ischemia -- Physiological aspects, Health
Abstract

Anticardiolipin antibodies (acLa) are associated with a thrombotic tendency (often involving cerebral ischemic events), are frequently present with systemic lupus erythematosus and have been found together with cardiac valve abnormalities. Previous studies evaluated patients characterized by the presence of acLa or lupus, precluding assessment of the frequency of acLa in those with valvular disease. This study aims to establish the prevalence of acLa in patients with valve disease in the absence of lupus and, furthermore, to determine the influence of acLa on the risk of cerebral events in valve disease. Eighty-seven consecutive patients with mitral or aortic regurgitation, or both, prospectively underwent enzyme-linked immunosorbent assay testing for immunoglobulin G (IgG) and M acLa, as did 24 normal subjects. AcLa values [is greater than or equal to] 3 SD above the normal mean were considered 'positive.' Prior cerebral events were defined retrospectively. Of 87 patients with valvular disease, 26 had positive IgG acLa levels compared with 0 of 24 normal subjects (p

Published
1992

36. Abstract TP184: Half of All Patients With or WIthout a History of Treatment for Hypertension Fail a Blood Pressure Screening: An innovative Urban Eye Clinic Experience

Author

Dul, Mitchell, primary, Nachman, Sharon, additional, Arnedo, Vanessa, additional, Balucani, Clotilde, additional, Burton, Dee, additional, Pandey, Abhishek, additional, El Zammar, Ziad, additional, Borer, Jeffrey, additional, Supino, Phyllis, additional, and Levine, Steven R, additional

Published
2013
Full Text
View/download PDF

39. PLASMA TRAIL AND OSTEOPROTEGERIN IN AR, AS AND STABLE CAD: RELATION TO CARDIAC GEOMETRY AND SYMPTOM STATUS

Author

Catanzaro, Daniel, primary, Supino, Phyllis G., additional, Herrold, Edmund M., additional, Stuart, Christopher, additional, Hong, Ji-Sun, additional, Ene, Ada E., additional, Carter, John N., additional, Lazar, Jason, additional, Salciccioli, Lou, additional, Ko, Wilson, additional, Salemi, Arash, additional, Girardi, Leonard, additional, Krieger, Karl H., additional, Isom, O. Wayne, additional, and Borer, Jeffrey S., additional

Published
2011
Full Text
View/download PDF

42. PLASMA BIOMARKERS OF COLLAGEN AND FIBRONECTIN BIOSYNTHESIS ARE UNRELATED TO TISSUE IMUNOHISTOCHEMICAL PROTEIN QUANTIFICATION OR MRNA DETERMINED BY MYOCARDIAL BIOSPY MICROARRAY IN AORTIC VALVE DISEASE

Author

Catanzaro, Daniel, primary, Stuart, Christopher, additional, Hong, Ji-Sun, additional, Ene, Ada, additional, Carter, John, additional, Herrold, Edmund, additional, Supino, Phyllis, additional, Lazar, Jason, additional, Salciccioli, Lou, additional, Ko, Wilson, additional, Salemi, Arash, additional, Girardi, Leonard, additional, Krieger, Karl, additional, Isom, O. Wayne, additional, and Borer, Jeffrey, additional

Published
2010
Full Text
View/download PDF

43. MYOCARDIAL MRNA CONCENTRATIONS FOR SECRETED BIOMARKERS IN AORTIC REGURGITATION VS AORTIC STENOSIS: CORRELATIONS WITH PLASMA PROTEIN CONCENTRATIONS AND LEFT VENTRICULAR DIMENSIONS

Author

Catanzaro, Daniel, primary, Stuart, Christopher, additional, Hong, Ji-Sun, additional, Ene, Ada, additional, Carter, John, additional, Herrold, Edmund, additional, Supino, Phyllis G., additional, Lazar, Jason, additional, Salciccioli, Lou, additional, Ko, Wilson, additional, Salemi, Arash, additional, Girardi, Leonard, additional, Krieger, Karl H., additional, Isom, O. Wayne, additional, and Borer, Jeffrey S., additional

Published
2010
Full Text
View/download PDF

49. Survival after valve replacement for aortic regurgitation: Prediction from noninvasive contractility measurement and comparison with census-expected survival

Author

Borer, Jeffrey S., primary, Herrold, Edmund M., additional, Supino, Phyllis G., additional, Hochreiter, Clare A., additional, Devereux, Richard B., additional, Roman, Mary J., additional, Kligfield, Paul D., additional, Isom, O.Wayne, additional, Krieger, Karl H., additional, Yin, Andrew, additional, Hearne, Leonard, additional, and Ross, N.Philip, additional

Published
2003
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results